Imuvant - A Novel Adjuvant; Efficacy and Safety Properties in Hyogen Vaccine
The aim of this study by Ceva was to assess the safety of Hyogen® and evaluate the boosting effect of the J5 component of Imuvant™ on the efficacy of Hyogen® vaccine in 3-week-old piglets, write Miklós Tenk, Anna Kollár, Ferenc Misák, Mariann Ivók, Nimród Pálmai and Zoltán Pénzes, Ceva.
19 February 2016
2 minute read
By: 
